Wednesday, August 17, 2022 11:57:16 PM
Thanks Gio,
guess it isn't going to help then lol.
ps. and can't belive this.
but if the Data is as good as expected near future it won't matter :)
guess it isn't going to help then lol.
ps. and can't belive this.
In the next 3-5 days one can expect to see some substantial buying. Brokerages will adjust to find borrow for its most highest paying clients. But there’s will be overall less downward pressure on these names going forward.
— Betting Bruiser (@BettingBruiser) August 17, 2022
but if the Data is as good as expected near future it won't matter :)
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
